Patent details

Basic Information

Publication number:

EP2526115

PCT Application Number:

EP2011050594

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117005470

PCT Publication Number:

WO2011086197

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PURIFICATION OF BLOOD COAGULATION FACTORS

French Title of Invention:

PURIFICATION DES FACTEURS DE COAGULATION SANGUINE

German Title of Invention:

REINIGUNG VON BLUTGERINNUNGSFAKTOREN

SPC Number:

Dates

Filing date:

18/01/2011

Grant date:

01/08/2018

EP Publication Date:

28/11/2012

PCT Publication Date:

21/07/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/08/2018

EP B1 Publication Date:

01/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/01/2019

Expiration date:

18/01/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/07/2018

 

 

Name:

Novo Nordisk Health Care AG

Address:

Andreasstrasse 15, 8050 Zürich, Switzerland (CH)

Inventor

Name:

BJELKE, Jais, Rose

Address:

Denmark (DK)

Priority

1

Priority Number:

10150980

Priority Date:

18/01/2010

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

297011 P

Priority Date:

21/01/2010

Priority Country:

United States (US)

Classification

IPC classification:

C07K 1/22; C07K 14/745; C12N 9/64;

Publication

European Patent Bulletin

Issue number:

201831

Publication date:

01/08/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/05/2019	Outgoing Correspondence	1